Panacea Biotec Pharma Limited

Panacea Biotec Pharma Limited - pharma in New Delhi, Delhi, India. FY 2026 financials & compliance.
CIN U24299DL2019PLC347566 Incorporated 22 March 2019 ROC Delhi HQ New Delhi, Delhi, India
Active Public Limited Company pharma
Data last updated
Revenue · FY 2025
₹265.23 Cr
▲ 26.00% YoY
EBITDA · FY 2025
Locked
In full report
Net profit · FY 2025
Locked
In full report
Authorised capital
₹60 Cr
Registered with MCA
Paid-up capital
₹10 Lakh
Issued & subscribed
Open charges
None
Satisfied ₹1,618.44 Cr
Company age
7 yrs
Est. 2019
Employees · EPFO
749
Latest available

About Panacea Biotec Pharma Limited

Data last updated:

Panacea Biotec Pharma Limited is a public limited company based in New Delhi, Delhi, India, a subsidiary of Panacea Biotec Limited. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 22 March 2019 and has been in existence for over 7 years.

The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24299DL2019PLC347566. Its GSTIN is 07AAKCP4431B1ZQ (Delhi). The company holds 22 GST registrations, of which 21 are active.

The company has an authorised share capital of ₹60 Cr and a paid-up capital of ₹10 Lakh. It is led by directors including Rajesh Jain (Managing Director) and Ankesh Jain (Whole-Time Director).

Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at B – 1 Extension/A – 27 Mohan Co – Operative Industrial Estate Mathura Road, New Delhi, Delhi, India – 110044.

As per the financials filed for FY 2025, the company reported a revenue of ₹265.23 Cr, a growth of 26% compared to the previous year.

The company has about 749 employees on its provident fund (EPFO) records.

The company is associated with 1 brand: Panacea Biotec. As per MCA filings, the company has satisfied charges of ₹1,618.44 Cr on record.

For more details, the company can be reached via its website panaceabiotec.com.

Company Details of Panacea Biotec Pharma Limited
CIN U24299DL2019PLC347566
Registration Number 347566
Incorporation Date 22 March 2019
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 29 September 2025
Date of Balance Sheet 31 March 2025
Parent Company Panacea Biotec Limited
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Social Media
    Locked
  • Registered Address
    B – 1 Extension/A – 27 Mohan Co – Operative Industrial Estate Mathura Road, New Delhi, Delhi, India – 110044
  • Industry
    Pharma, Drug Formulation & Development
Company report
Panacea Biotec Pharma Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Panacea Biotec Pharma Limited report

Financials, compliance, directors, charges, ownership and filings for Panacea Biotec Pharma Limited in one report.

10-year financials Directors & ownership Charges & compliance

CIN History of Panacea Biotec Pharma

Panacea Biotec Pharma has one previous CIN (Corporate Identification Number): U24299PB2019PLC068319. The current CIN is U24299DL2019PLC347566, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U24299DL2019PLC347566Current
U24299PB2019PLC068319Previous

Associated Brands with Panacea Biotec Pharma

Panacea Biotec Pharma operates one associated brand: Panacea Biotec. Each brand links to its own profile.

BrandDescriptionWebsite
Developer of biosimilars, vaccines and natural productspanaceabiotec.com

Competitors & Alternatives of Panacea Biotec Pharma

Brands and companies operating in the same space as Panacea Biotec Pharma Limited include Abzena, Syngene, Grand River Aseptic Manufacturing and 5 more.

CompetitorDescriptionLocationFounded
Abzena Abzena Provider of antibody discovery, cell line development, and bio analytics servicesCambridge, United Kingdom, United Kingdom2001
Syngene Syngene Provider of contract research and manufacturing services for both small molecules and biologicsBengaluru, India, India1993
Grand River Aseptic Manufacturing Grand River Aseptic Manufacturing Sterile parenteral CDMO services for development and manufacturing are offered.Grand Rapids, United States, United States2010
Patheon Patheon Commercial manufacturing and pharmaceutical development services for biopharmaceutical industryDurham, United States, United States1974
Piramal Group Piramal Group Multinational conglomerate with diverse interests in Pharma, Financial Services and Real EstateMumbai, India, India1984
Maravai Life Sciences Maravai Life Sciences Provides enabling tools and services in the life sciences research and bio-production industriesSan Diego, United States, United States2014
LakePharma LakePharma Provider of drug discovery on molecular biology, viral vectors and cell & protein engineeringBelmont, United States, United States2009
Insud Pharma Insud Pharma Finished formulations, APIs, and monoclonal antibodies are developed and manufactured.Madrid, Spain, Spain1977

Business Activity of Panacea Biotec Pharma

The main business activity of Panacea Biotec Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main Activity Group CodeDescription of Main ActivityBusiness Activity CodeDescription of Business ActivityTurnover Percentage
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical productsLocked
Premium access

Business activity turnover details for Panacea Biotec Pharma Limited

Turnover share and past changes in activity are in the company report.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Auditor Details of Panacea Biotec Pharma

Panacea Biotec Pharma Limited is audited by Walker Chandiok & Co LLP for the financial year 2023.

NameStatusAppointment DateCessation Date
Walker Chandiok & Co LLPLockedLockedLocked
Premium access

Complete auditor history for Panacea Biotec Pharma Limited

Appointment and cessation dates and past auditor changes are in the company report.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors of Panacea Biotec Pharma Limited

Panacea Biotec Pharma has 6 current directors and 11 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Ankesh JainWhole-Time Director22 Mar 20197 Years 6 MonthsCurrent
Rajesh JainDirector12 Nov 20241 Years 10 MonthsCurrent
Manjula UpadhyayDirector23 Jul 20215 Years 2 MonthsCurrent
Narotam Kumar JunejaWhole-Time Director01 Apr 20224 Years 6 MonthsCurrent
Rajesh JainManaging Director22 Mar 20197 Years 6 MonthsCurrent
Sanjay TrehanWhole-Time Director13 Feb 20251 Years 7 MonthsCurrent

Financials of Panacea Biotec Pharma Limited FY 2025 filings available

Panacea Biotec Pharma Limited reported revenue of ₹265.23 Cr (up 26.00% YoY) for FY 2025.

Revenue · FY 2025
₹265.23 Cr ▲ 26.00%
Premium access

Ten-year financial statements for Panacea Biotec Pharma Limited

Earlier years and trend charts are in the company report.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Ownership and Shareholding of Panacea Biotec Pharma

Premium access

Shareholding and ownership data for Panacea Biotec Pharma Limited

Promoter, institutional, public and beneficial ownership figures are in the company report.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings of Panacea Biotec Pharma

Open charges
₹0
Satisfied charges
₹1,618.44 Cr
Breakdown by lending institutions
Others₹1,618.44 Cr
Latest charge details
DateLenderAmountStatus
01 Feb 2020Others₹754.44 CrSatisfied
06 Apr 2019Others₹864 CrSatisfied

Total charge records: 2 View all charges

Employees and EPFO Compliance at Panacea Biotec Pharma

Panacea Biotec Pharma Limited has a workforce of 749 employees as of Mar 25, 2024.

Employee count
749
Active EPFO establishments
1
Employee growth
14.53%
Premium access

Employee and EPFO history for Panacea Biotec Pharma Limited

Monthly headcount, contribution history and filing status are in the company report.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Panacea Biotec Pharma

Panacea Biotec Pharma has 22 GST registrations: 21 active and 1 cancelled or inactive. The first 4 active GSTINs are listed below.

Total GSTINs
22
Active
21
Cancelled / inactive
1
GSTINStateStatusRegistered on
07AAKCP4431B1ZQDelhiActive16 Apr 2019
07AAKCP4431B2ZPDelhiActive04 Jul 2020
18AAKCP4431B1ZNAssamActive13 Aug 2019
24AAKCP4431B1ZUGujaratActive14 Aug 2019
Premium access

GST registrations and filing compliance for Panacea Biotec Pharma Limited

State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Panacea Biotec Pharma

Premium access

Credit ratings, litigation, and regulatory alerts for Panacea Biotec Pharma Limited

Credit ratings, court records and regulatory alerts are in the company report.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Panacea Biotec Pharma

Premium access

MSME payment history for Panacea Biotec Pharma Limited

Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Panacea Biotec Pharma

Premium access

Corporate group structure for Panacea Biotec Pharma Limited

Parent, subsidiary, associate and joint venture records with holdings are in the company report.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Panacea Biotec Pharma

Premium access

MCA filings and documents for Panacea Biotec Pharma Limited

Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Panacea Biotec Pharma

Activity
29 Sep 2025
Panacea Biotec Pharma Limited last Annual general meeting of members was held on 29 Sep 2025 as per latest MCA records.
Activity
31 Mar 2025
Panacea Biotec Pharma Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi.
Directors
13 Feb 2025
Sanjay Trehan was appointed as a Whole-time director on 13 Feb 2025 & has been associated with this company since 1 year 7 months.
Directors
12 Nov 2024
Rajesh Jain was appointed as a Director on 12 Nov 2024 & has been associated with this company since 1 year 10 months.
Directors
01 Apr 2022
Narotam Kumar Juneja was appointed as a Whole-time director on 01 Apr 2022 & has been associated with this company since 4 years 6 months.
Charges
03 Mar 2022
A charge registered on 01 Feb 2020 via Charge ID 100332250 with Others was fully satisfied on 03 Mar 2022.

Frequently Asked Questions about Panacea Biotec Pharma Limited

Panacea Biotec Pharma is an active public limited company based in New Delhi, Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 22 March 2019 (7+ years old) and is registered under CIN U24299DL2019PLC347566.

Panacea Biotec Pharma reported revenue of ₹265.23 Cr for FY 2025 (up 26.00% YoY).

Panacea Biotec Pharma has 6 current directors:

The GSTIN of Panacea Biotec Pharma is 07AAKCP4431B1ZQ, registered in Delhi. The company has 22 GST registrations in all, of which 21 are active and 1 is cancelled or inactive. Other active GSTINs include 07AAKCP4431B2ZP (Delhi), 18AAKCP4431B1ZN (Assam), 24AAKCP4431B1ZU (Gujarat).

The CIN (Corporate Identification Number) of Panacea Biotec Pharma is U24299DL2019PLC347566. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Panacea Biotec Pharma was incorporated on 22 March 2019, making it 7+ years old. It is registered with the Registrar of Companies, Delhi.

Panacea Biotec Pharma can be reached through the website panaceabiotec.com. Its registered office is in New Delhi, Delhi, India.

The registered office of Panacea Biotec Pharma is at B – 1 ExtensionA – 27 Mohan Co – Operative Industrial Estate Mathura Road, New Delhi, Delhi, India – 110044.

Panacea Biotec Pharma has an authorised share capital of ₹60 Cr and a paid-up capital of ₹10 Lakh.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available